1. Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food & Drug Administration . Report on the state of pharmaceutical quality, 2018: assuring quality medicines are available for the American public. Date unknown. Accessed October 28, 2021. https://www.fda.gov/media/125001/download.
Google Scholar2. Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food & Drug Administration . Report on the state of pharmaceutical quality: fiscal year 2020: assuring quality medicines are available to the American public. Published August 2021. Accessed October 18, 2021. https://www.fda.gov/media/151561/download.
Google Scholar3. Eban, K. Bottle of Lies: The Inside Story of the Generic Drug Boom. New York, NY: HarperCollins Publishers; 2019.
Google Scholar4. White, CM. Generic drugs are not as safe as FDA wants you to believe. Ann Pharmacother. 2020;54(3):283-286. doi:10.1177/1060028019881692.
Google Scholar | SAGE Journals | ISI5. Flavin, BM, Happe, LE, Hatton, RC. Meeting report: an exploration into the scientific and regulatory aspects of pharmaceutical drug quality in the United States. Expert Opin Drug Saf. Published online December 31, 2021. doi: 10.1080/14740338.2022.2020244.
Google Scholar | Crossref6. The White House . Building resilient supply chains, revitalizing American manufacturing, and fostering broad-based growth: 100-day reviews under executive order 14017. Published June 2021. Accessed October 19, 2021. https://www.whitehouse.gov/wp-content/uploads/2021/06/100-day-supply-chain-review-report.pdf.
Google Scholar7. Country of origin labeling for fish and shellfish . 7 USC 1621 § 60.200. January 1, 2021. Accessed October 28, 2021. https://www.govinfo.gov/content/pkg/CFR-2021-title7-vol3/xml/CFR-2021-title7-vol3-part60.xml.
Google Scholar8. Chang, P. Country of origin labeling: history and public choice theory. Food Drug Law J. 2009;64(4):693-715.
Google Scholar9. 21 CFR § 201.1–drugs; name and place of business of manufacturer, packer or distributor . April 1, 2021 Accessed October 28, 2021. https://www.govinfo.gov/content/pkg/CFR-2021-title21-vol7/xml/CFR-2021-title21-vol7-sec701-12.xml.
Google Scholar10. The Pew Charitable Trusts . FDA globalization act of 2009: drug safety provisions. Published June 10, 2009. Accessed October 27, 2021. https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2009/06/10/fda-globalization-act-of-2009-drug-safety-provisions.
Google Scholar11. Brechtelsbauer, ED, Pennell, B, Durham, M, Hertig, JB, Weber, RJ. Review of the 2015 drug supply chain security act. Hosp Pharm. 2016;51(6):493-500. doi:10.1310/hpj5106-493.
Google Scholar | SAGE Journals12. Hatton, RC, Leighton, G, Englander, L. Countries manufacturing pharmaceuticals for the United States market: a 10-year analysis of public data. Ann Pharmacother.
Google Scholar13. 21 CFR § 314.430 availability for public disclosure of data and information in an application or abbreviated application . n.d. Accessed December 1, 2021. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-314/subpart-G/section-314.430.
Google Scholar14. Cama, J, Leszczynski, R, Tang, PK, et al To push or pull? In a post-COVID world, supporting and incentivizing antimicrobial drug development must become a governmental priority. ACS Infect Dis. 2021;7:2029-2042. doi:10.2021/acsinfecdis.0c00681.
Google Scholar | Crossref | Medline15. US Food & Drug Administration . Advanced manufacturing. n.d. Accessed October 27, 2021. https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/advanced-manufacturing.
Google Scholar16. Phlow Corporation . Phlow corporation awarded $354 million HHS/ASPR/BARDA contract to manufacture essential medicines in shortage: move strengthens America’s supply chain and supports COVID-19 response. Published May 19, 2020. Accessed October 27, 2021. https://www.prnewswire.com/news-releases/phlow-corporation-awarded-354-million-hhsasprbarda-contract-to-manufacture-essential-medicines-in-shortage-301061648.html.
Google Scholar17. US Food & Drug Administration . Guidance for industry: labeling for human prescription drug and biological products—implementing the PLR content and format requirements. Published February 2013. Accessed October 27, 2021. https://www.fda.gov/media/71836/download.
Google Scholar18. 21 CFR § 206 imprinting of solid oral dosage form drug products for human use . Date unknown. Accessed October 28, 2021. https://www.govinfo.gov/content/pkg/CFR-2021-title21-vol4/xml/CFR-2021-title21-vol4-sec206-10.xml.
Google Scholar19. Dabestani, A, Bazil, CW, Costantino, R, et al Evidence-based quality scores for rating drug products and their utility in health systems. medRxiv. 2020. doi:10.1101/2020.05.22.20110775.
Google Scholar | Crossref20. Eban, K, Salzman, S. In generic drug plants in China and India, data falsification is still a problem. STAT. October 29, 2019. Accessed October 19, 2021. https://www.statnews.com/2019/10/29/data-falsification-still-problematic-china-india-generic-drug-plants/.
Google Scholar21. US Government Accountability Office . Testimony before the subcommittee on oversight and investigations, committee on energy and commerce, house of representatives. Drug safety. Preliminary findings indicate persistent challenges with FDA foreign inspection: statement of Mary Denigan-Macauley. Published December 10, 2019. Accessed November 24, 2021. https://www.gao.gov/assets/gao-20-262t.pdf.
Google Scholar